Literature DB >> 497336

Hazard rate models with covariates.

R L Prentice, J D Kalbfleisch.   

Abstract

Many problems, particularly in medical research, concern the relationship between certain covariates and the time to occurrence of an event. The hazard or failure rate function provides a conceptually simple representation of time to occurrence data that readily adapts to include such generalizations as competing risks and covariates that vary with time. Two partially parametric models for the hazard function are considered. These are the proportional hazards model of Cox (1972) and the class of log-linear or accelerated failure time models. A synthesis of the literature on estimation from these models under prospective sampling indicates that, although important advances have occurred during the past decade, further effort is warranted on such topics as distribution theory, tests of fit, robustness, and the full utilization of a methodology that permits non-standard features. It is further argued that a good deal of fruitful research could be done on applying the same models under a variety of other sampling schemes. A discussion of estimation from case-control studies illustrates this point.

Entities:  

Mesh:

Year:  1979        PMID: 497336

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  24 in total

1.  Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT.

Authors:  Paul F Pinsky; P Hrudaya Nath; David S Gierada; Sushil Sonavane; Eva Szabo
Journal:  Cancer Prev Res (Phila)       Date:  2014-04-22

2.  Raltegravir in second-line antiretroviral therapy in resource-limited settings (SELECT): a randomised, phase 3, non-inferiority study.

Authors:  Alberto M La Rosa; Linda J Harrison; Babafemi Taiwo; Carole L Wallis; Lu Zheng; Peter Kim; Nagalingeswaran Kumarasamy; Mina C Hosseinipour; Bernadette Jarocki; John W Mellors; Ann C Collier
Journal:  Lancet HIV       Date:  2016-04-18       Impact factor: 12.767

3.  Protein Intake and Breast Cancer Survival in the Nurses' Health Study.

Authors:  Michelle D Holmes; Jun Wang; Susan E Hankinson; Rulla M Tamimi; Wendy Y Chen
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

4.  Predictive comparison of joint longitudinal-survival modeling: a case study illustrating competing approaches.

Authors:  Timothy E Hanson; Adam J Branscum; Wesley O Johnson
Journal:  Lifetime Data Anal       Date:  2010-04-06       Impact factor: 1.588

5.  Life table transformations and inequality measures: some noteworthy formal relationships.

Authors:  R Hakkert
Journal:  Demography       Date:  1987-11

Review 6.  Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.

Authors:  Dejana Braithwaite; Monika Izano; Dan H Moore; Marilyn L Kwan; Martin C Tammemagi; Robert A Hiatt; Karla Kerlikowske; Candyce H Kroenke; Carol Sweeney; Laurel Habel; Adrienne Castillo; Erin Weltzien; Bette Caan
Journal:  Breast Cancer Res Treat       Date:  2012-09-29       Impact factor: 4.872

7.  Homotypic and heterotypic protection and risk of re-infection following natural norovirus infection in a highly endemic setting.

Authors:  Preeti Chhabra; Saba Rouhani; Hannah Browne; Pablo Peñataro Yori; Mery Siguas Salas; Maribel Paredes Olortegui; Lawrence H Moulton; Margaret N Kosek; Jan Vinjé
Journal:  Clin Infect Dis       Date:  2020-01-09       Impact factor: 9.079

8.  Childhood obesity, other cardiovascular risk factors, and premature death.

Authors:  Paul W Franks; Robert L Hanson; William C Knowler; Maurice L Sievers; Peter H Bennett; Helen C Looker
Journal:  N Engl J Med       Date:  2010-02-11       Impact factor: 91.245

9.  Pre-diagnostic sex hormone levels and survival among breast cancer patients.

Authors:  Kevin H Kensler; A Heather Eliassen; Bernard A Rosner; Susan E Hankinson; Myles Brown; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2019-01-02       Impact factor: 4.872

10.  Homocysteine as a risk factor for nephropathy and retinopathy in Type 2 diabetes.

Authors:  H C Looker; A Fagot-Campagna; E W Gunter; C M Pfeiffer; K M Venkat Narayan; W C Knowler; R L Hanson
Journal:  Diabetologia       Date:  2003-05-28       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.